Journals / Alpha psychiatry (Online) / 2021 / Cilt: 22 - Sayı: 2

Delirium After Pregabalin Withdrawal

Pages
118–119
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case report describesa 68-year-old patient who developed delirium after experiencing pregabalin withdrawal.Clinicians should be aware of the possibility of pregabalin withdrawal delirium.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pregabalin is a γ-amino butyric acid analogue drug that is used in fibromyalgia, neuropathicpain associated with diabetic peripheral neuropathy, spinal cord injury, and postherpeticneuralgia.
📊
Key Findings & Data:Symptoms reported in association with pregabalin withdrawal includeinsomnia, gastrointestinal distress, tachycardia, and headache.
💡
Conclusion & Impact:This case report describesa 68-year-old patient who developed delirium after experiencing pregabalin withdrawal.Clinicians should be aware of the possibility of pregabalin withdrawal delirium.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pregabalin is a γ-amino butyric acid analogue drug that is used in fibromyalgia, neuropathicpain associated with diabetic peripheral neuropathy, spinal cord injury, and postherpeticneuralgia. Symptoms reported in association with pregabalin withdrawal includeinsomnia, gastrointestinal distress, tachycardia, and headache. This case report describesa 68-year-old patient who developed delirium after experiencing pregabalin withdrawal.Clinicians should be aware of the possibility of pregabalin withdrawal delirium.

🔖

Cite This Article

EREN, İ., İNANLI, İ., ÇALIŞKAN, A. M., ÇALIŞKAN, S. (2022). Delirium After Pregabalin Withdrawal. Alpha psychiatry (Online), Cilt: 22 - Sayı: 2, 118–119. https://ajindex.com/articles/435214

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010;49(10):661-669. [Crossref] 2. Kim KH, Lim SH, Shim CR, et al. Development of a novel controlled-release tablet of pregabalin: formulation variation and pharmacokinetics in dogs and humans. Drug Des Devel Ther. 2020;14:445-456. [Crossref] 3. Federico CA, Mogil JS, Ramsay T, Fergusson DA, Kimmelman J. A systematic review and meta-analysis of pregabalin preclinical studies. Pain. 2020;161(4):684-693. [Crossref] 4. Goodman CW, Brett AS. A clinical overview of off-label use of gabapentinoid drugs. JAMA Intern Med. 2019;179(5):695-701. [Crossref] 5. Nordgaard J, Jürgens G. Pregabalin can cause addiction and withdrawal symptoms. Ugeskr Laeger. 2015;177(2):38-39. 6. Mezaki N, Ishihara T, Ozawa T. Patient with insidious hypoactive delirium associated with pregabalin. Neurol Clin Neurosci. 2013;1(5):177-178. [Crossref] 7. Pedroso JL, Nakama GY, Filho MC, Barsottini OG. Delirium, psychosis, and visual hallucinations induced by pregabalin. Arq Neuropsiquiatr. 2012;70(12):960-961. [Crossref] 8. Hickey C, Thomas B. Delirium secondary to pregabalin. Gen Hosp Psychiatry. 2012;34(4): 436.e1-436.e2. [Crossref] 9. Fabio R Di, D’Agostino C, Baldi G, et al. Delirium after gabapentin withdrawal. Case report. Can J Neurol Sci. 2013;40(1):126-127. [Crossref] 10. Oaklander AL, Buchbinder BR. Pregabalin-withdrawal encephalopathy and splenial edema: a link to high-altitude illness? Ann Neurol. 2005;58(2):309-312 [Crossref] 11. Gundogmus İ, Karagoz A, Algul A. First-episode psychosis induced by pregabalin withdrawal: a case report. Psychiatry Clin Psychopharmacol. 2018;28(4):461-463. [Crossref] 12. Barrett J, Kittler L, Singarajah C. Acute pregabalin withdrawal: a case report and review of the literature. Southwest J Pulm Crit Care. 2015;10(5):306-310. [Crossref]